Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Alpha IVF Group BhdXKLS:0303 54 EV-to-EBITDA is 14.45 as of Aug. 18, 2026, which is 12% below its 10-year median of 16.44. GuruFocus rates XKLS:0303 with a GF Score™ of 54/100. The stock has 2 warning signs investors should review. Among 511 Healthcare Providers & Services companies, Alpha IVF Group Bhd ranks worse than 63.99% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Alpha IVF Group Bhd's enterprise value is RM1,235.5 Mil.
Alpha IVF Group Bhd's EBITDA for the trailing twelve months (TTM) ended in May. 2026 was RM85.5 Mil. Therefore, Alpha IVF Group Bhd's EV-to-EBITDA for today is 14.45.
The historical rank and industry rank for Alpha IVF Group Bhd's EV-to-EBITDA or its related term are showing as below:
XKLS:0303'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 12.49 Med: 16.44 Max: 83.12
Current: 14.46
During the past 7 years, the highest EV-to-EBITDA of Alpha IVF Group Bhd was 83.12. The lowest was 12.49. And the median was 16.44.
XKLS:0303's EV-to-EBITDA is ranked worse than 63.99% of 511
companies
in the Healthcare Providers & Services industry
Industry Median: 10.66
vs XKLS:0303: 14.46
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Alpha IVF Group Bhd (XKLS:0303) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Alpha IVF Group Bhd's PE Ratio (TTM) for today is calculated as:
Alpha IVF Group Bhd's share price for today is RM0.275.
Alpha IVF Group Bhd's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in May. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was RM0.012.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for Alpha IVF Group Bhd's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XKLS:0303 vs HCA, THC, DVA: EV-to-EBITDA Comparison
For the Medical Care Facilities subindustry, Alpha IVF Group Bhd's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Alpha IVF Group Bhd EV-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Alpha IVF Group Bhd's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Alpha IVF Group Bhd's EV-to-EBITDA falls into.
Alpha IVF Group Bhd's current Enterprise Value is RM1,235.5 Mil.
Alpha IVF Group Bhd's EBITDA for the trailing twelve months (TTM) ended in May. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was RM85.5 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Alpha IVF Group Bhd (XKLS:0303) has a EV-to-EBITDA of 14.45 as of Aug. 18, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Alpha IVF Group Bhd. This is 12% below median its historical median of 16.44. Over the past decade, Alpha IVF Group Bhd's EV-to-EBITDA has ranged from 12.49 to 83.12. According to the industry distribution chart, Alpha IVF Group Bhd ranks #327 out of 511 companies in the Healthcare Providers & Services industry, placing it in the top 64%.
Is Alpha IVF Group Bhd's EV-to-EBITDA too high?
Alpha IVF Group Bhd's current EV-to-EBITDA of 14.45 is 12% below median its 10-year median of 16.44. Over the past 10 years, this metric has ranged from a low of 12.49 to a high of 83.12. The Healthcare Providers & Services industry median EV-to-EBITDA is 10.66. Alpha IVF Group Bhd's value of 14.45 is 35.6% above this industry median. Based on the distribution chart, Alpha IVF Group Bhd ranks #327 out of 511 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Alpha IVF Group Bhd has a GF Score™ of 54/100, reflecting its overall financial health beyond just this single metric.
How does Alpha IVF Group Bhd's EV-to-EBITDA compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Alpha IVF Group Bhd ranks #327 out of 511 companies for EV-to-EBITDA. This places Alpha IVF Group Bhd in the lower half of its industry. The industry median EV-to-EBITDA is 10.66. Alpha IVF Group Bhd's value of 14.45 is 35.6% above this benchmark. Historically, Alpha IVF Group Bhd's own EV-to-EBITDA has ranged from 12.49 to 83.12 over the past decade. While the company's 10-year median is 16.44 vs. the industry median of 10.66, Alpha IVF Group Bhd has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Healthcare Providers & Services company?
The median EV-to-EBITDA among Healthcare Providers & Services companies is 10.66, based on 511 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Alpha IVF Group Bhd's current EV-to-EBITDA of 14.45 is 35.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Alpha IVF Group Bhd. For the Healthcare Providers & Services industry, the median EV-to-EBITDA is 10.66 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Alpha IVF Group Bhd's current EV-to-EBITDA is 14.45, which is 12% below median its own 10-year median of 16.44. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alpha IVF Group Bhd stock overvalued right now?
Alpha IVF Group Bhd (XKLS:0303) has a current EV-to-EBITDA of 14.45. The current EV-to-EBITDA is 14.45, which is 12% below median its 10-year median of 16.44 and 35.6% above the Healthcare Providers & Services industry median of 10.66. Alpha IVF Group Bhd's overall GF Score™ is 54/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Alpha IVF Group Bhd (XKLS:0303), the current EV-to-EBITDA is 14.45 as of Aug. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Alpha IVF Group Bhd is a fertility care specialist focusing on assisted reproductive services in Malaysia, Singapore, Indonesia, and China, with the majority of its revenue coming from Malaysia. Assisted reproductive services is a general term that includes all types of fertility treatments and procedures to help people facing difficulties in getting pregnant. The company offers a range of assisted reproductive services such as IVF to assist patients with infertility conditions in achieving clinical pregnancy. It also provides other procedures including intracytoplasmic sperm injection (ICSI), intrauterine insemination (IUI), various diagnostic, testing, and screening procedures, as well as cryopreservation of eggs, sperm, and embryos.
54GF Score
Get the complete analysis for XKLS:0303
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:0303 has been successfully added to your 
